Home Overview Press Room Blog Publications For Students about us
Search



California’s Stem Cell Agency “Stacks the Deck” at a Key Hearing by Marcy Darnovsky - Jan 24, 2012 Biopolitical Times A meaningful review of the stem cell program by the Institute of Medicine could make an important contribution to needed changes at the agency.
Make Me a Baby As Fast As You Can How a California surrogacy operation streamlines baby production by implanting clients’ embryos in two Indian surrogates at the same time by Douglas Pet - Jan 09, 2012 Slate If for-profit companies are going to continue to approach baby-making like an import-export business, maybe it’s time for governments to start treating it that way, adapting oversight and protections for all parties involved.
News of the Year 2011 by Pete Shanks - Dec 22, 2011 Biopolitical Times Sex selection, surrogacy and gamete donation became public controversies; shock waves rocked the stem-cell business; and other news of the year.
Cloning Technology: Control the Bonanza for Research Eggs [Letter to the editor] by Marcy Darnovsky, Susan Berke Fogel, Judy Norsigian - Dec 01, 2011 Nature The demand for women’s eggs for research could soar alarmingly following a report of a new cloning technique.
Life, Monetized Deadly Monopolies: The Shocking Corporate Takeover of Life Itself — And the Consequences for Your Health and Our Medical Future, by Harriet A. Washington by Osagie K. Obasagie - Nov 17, 2011 The American Prospect Harriet Washington's new book examines the ways in which the “medical-industrial complex” benefits research industries at the expense of both consumers and human research subjects.


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications | about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.625.0819 • (F) 1.510.665.8760